Stay updated on Belzutifan + Cabozantinib in ccRCC Clinical Trial
Sign up to get notified when there's something new on the Belzutifan + Cabozantinib in ccRCC Clinical Trial page.

Latest updates to the Belzutifan + Cabozantinib in ccRCC Clinical Trial page
- Check6 days agoChange DetectedA top notice informs users of a lapse in government funding and states that the information may not be up to date, with the NIH Clinical Center open and status updates available at opm.gov. The site revision history shows an update to version v3.4.1 (removing v3.4.0); To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check13 days agoChange DetectedAdded a 'Show glossary' option and updated QC/version metadata (Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0), replacing the previous lowercase/counterparts.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe changes are limited to revision labels (the page now shows Revision: v3.3.4 and previously displayed v3.3.3), which are minor metadata updates and do not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedA new 'Locations' section consolidates participating sites by state (CA, FL, MA, MI, TN, TX, WA) and replaces the previous per-state location subsections. The page revision label updated from v3.3.2 to v3.3.3.SummaryDifference0.8%

- Check71 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2, as shown on the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check78 days agoChange DetectedPublications section wording updated to clarify data sources: publications are automatically filled in from PubMed (not created by ClinicalTrials.gov) and a revision tag v3.3.1 was added. The description also slightly rephrases how the publications relate to study results.SummaryDifference0.1%

Stay in the know with updates to Belzutifan + Cabozantinib in ccRCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belzutifan + Cabozantinib in ccRCC Clinical Trial page.